Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant tumor types, being the sixth leading cause of mortality worldwide and the fourth in Europe. Globally, it has a mortality/incidence ratio of 98%, and the 5-year survival rate in Europe is only 3%. Although risk factors, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Anabela G., Pulido, Catarina F., Machado, Manuela, Brito, Maria José, Couto, Nuno, Sousa, Olga, Melo, Sónia A., Mansinho, Hélder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651228/
https://www.ncbi.nlm.nih.gov/pubmed/34859257
http://dx.doi.org/10.3892/ijo.2021.5290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651228/
https://www.ncbi.nlm.nih.gov/pubmed/34859257
http://dx.doi.org/10.3892/ijo.2021.5290

Ejemplares similares